ProfileGDS5678 / 1422564_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 26% 26% 27% 27% 26% 26% 24% 26% 26% 27% 26% 27% 26% 26% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.6243226
GSM967853U87-EV human glioblastoma xenograft - Control 22.6063926
GSM967854U87-EV human glioblastoma xenograft - Control 32.6121527
GSM967855U87-EV human glioblastoma xenograft - Control 42.570327
GSM967856U87-EV human glioblastoma xenograft - Control 52.561326
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6770726
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.6047124
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5864226
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5841526
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6002927
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5876926
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5867827
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5926526
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6000226